Park Medi World Limited has issued a revised Investor Presentation detailing the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025. The presentation highlights steady operational performance and continued execution of the company's growth strategy during Q3 and 9M FY26. Management commentary indicates healthy revenue growth, supported by stable patient volumes and an improved case mix, with gradual ramp-up across newer and acquired hospitals. Margins remained broadly stable, reflecting ongoing integration and initial gestation of recent capacity additions. Strategic acquisitions during the period included Febris Multi-Speciality Hospital in New Delhi and KP Institute of Medical Sciences in Agra. The acquisition of KP Institute of Medical Sciences involved an all-cash transaction of approximately ₹245 crore for a 360-bed, NABH-accredited multi-super-speciality hospital, strengthening the company's presence in Uttar Pradesh. Febris Multi-Speciality Hospital, a 200-bed facility in a densely populated catchment area, was acquired through a wholly-owned subsidiary under the IBC process, enhancing access to affordable healthcare in a high-potential urban area and contributing to the goal of reaching 5,260 beds by March 2028. Financial highlights for Q3 FY26 show revenues of ₹410 crore and EBITDA of ₹99.4 crore, with an EBITDA margin of 24.25%. Profit After Tax (PAT) stood at ₹52.8 crore, with a PAT margin of 12.89% and an Earnings Per Share (EPS) of ₹1.35. For the nine months ended December 31, 2025 (9M FY26), revenues were ₹1,218.9 crore, EBITDA was ₹317.0 crore (EBITDA margin of 26.00%), PAT was ₹196.8 crore (PAT margin of 16.14%), and EPS was ₹5.09. The company continues its focus on disciplined capital allocation, balance sheet strength, and measured expansion, with immediate priorities including seamless integration of acquired assets, improving asset utilization, and driving sustainable profitability. Medium-term plans involve selectively pursuing growth opportunities while delivering affordable, high-quality healthcare.
